This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cancer immunotherapy: the beginning of the end of cancer?
BMC Medicine Open Access 05 May 2016
-
Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity
Scientific Reports Open Access 14 April 2016
-
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells
Stem Cell Research & Therapy Open Access 04 June 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
ORIGINAL RESEARCH PAPERS
Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 10 Sep 2012 (doi:10.1084/jem.20120822)
Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 10 Sep 2012 (doi:10.1084/jem.20120914)
FURTHER READING
Hsieh, C. S. et al. Selection of regulatory T cells in the thymus. Nature Rev. Immunol. 12, 157–167 (2012)
Rights and permissions
About this article
Cite this article
Papatriantafyllou, M. Neuropilin 1 — distinguishing TReg cell subsets. Nat Rev Immunol 12, 746–747 (2012). https://doi.org/10.1038/nri3323
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3323
This article is cited by
-
Cancer immunotherapy: the beginning of the end of cancer?
BMC Medicine (2016)
-
Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity
Scientific Reports (2016)
-
Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential
Cellular and Molecular Life Sciences (2016)
-
Combination cancer immunotherapy and new immunomodulatory targets
Nature Reviews Drug Discovery (2015)
-
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells
Stem Cell Research & Therapy (2013)